·Î±×ÀΠȸ¿ø°¡ÀÔ Á¤º¸¼öÁ¤

417	Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens.  [1]	¹Ú°æ¼÷	2009/01/13	371
416	Identification of p53-46F as a super p53 with an enhanced ability to induce p53-dependent apoptosis.  [17]	¹ÚÁøÈñ	2008/12/16	379
415	Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9.  [3]	ȲÀç·É	2008/12/02	343
414	Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets.  [11]	ÃÖ±Ô»ï	2008/11/25	376
413	The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.  [1573]	¿À¹ÌÁ¤	2008/11/04	12169
412	Targeting the active beta-catenin pathway to treat cancer cells.  [104]	±è¿µÃ¤	2008/10/21	586
411	Regulation of prostate cell growth and morphogenesis by Dickkopf-3.  [965]	À¯¿¹³ª	2008/10/07	565
410	A magnetic nanoprobe technology for detecting molecular interactions in live cells.  [3380]	¼ºº´ÁØ	2008/09/02	54614
409	Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis.  [76]	¹Ú°æ¼÷	2008/08/19	497
408	Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy.  [4280]	±è¿µÃ¤	2008/07/29	1753
407	Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.  [2]	Á¶¹ÎÈ­	2008/07/08	369
406	Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.  [419]	ÃÖ±Ô»ï	2008/06/17	1401
405	Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.  [167]	ȲÀç·É	2008/06/03	714
404	Serum protein markers for early detection of ovarian cancer.  [61]	ÇãÀçÈ£	2008/05/20	443
403	Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.  [72]	¼ºº´ÁØ	2008/04/29	498
402	Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development.	¹ÚÁؼö	2008/04/01	353
401	Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.  [1168]	ÀÌÀºÁÖ	2008/03/18	6874
400	Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.  [650]	ÇãÀçÈ£	2008/03/04	905
399	Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.  [2905]	ȲÀç·É	2008/02/19	13369
398	MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.  [14811]	ÃÖ±Ô»ï	2008/02/12	392

¸ñ·Ïº¸±â   ´ÙÀ½ÆäÀÌÁö   ±Û¾²±â

1 [2][3][4][5][6][7][8][9][10]..[21]   [´ÙÀ½ 10°³]

Copyright 1999-2010 Zeroboard / skin by zero